• FMC shareholders met on May 21, 2026, backing a dividend of EUR 1.49 per share for fiscal 2025.
• A new authorization to acquire and use treasury shares was adopted, enabling potential share buybacks over the next five years; the authorization itself does not confirm any new repurchase has been launched.
• Shareholders also ratified the actions of the management board and supervisory board for fiscal 2025.
• The company confirmed completion of its prior EUR 1 billion share buyback program, with 24,800,000 shares repurchased.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FMC - Fresenius Medical Care AG published the original content used to generate this news brief on May 21, 2026, and is solely responsible for the information contained therein.